JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Abstract Details

Activity Number: 99
Type: Invited
Date/Time: Monday, July 30, 2012 : 8:30 AM to 10:20 AM
Sponsor: Pharmaceutical Research and Manufacturers of America
Abstract - #303591
Title: Monitoring Adaptive Clinical Trials
Author(s): Zoran Antonijevic*+
Companies: Quintiles, Inc.
Address: 8 Teahouse Ct., Durham, NC, 27707,
Keywords: adative design ; monitoring ; case studies
Abstract:

The FDA Draft Guidance for Adaptive Design Clinical Trials identifies the operational bias as one of the greatest concerns associated with implementation of Adaptive Clinical Trials. The primary cause of the operational bias is the information leakage during the unblinded interim analysis. The focus of this presentation will be on the adaptive clinical trials interim decision process and the information flow during interim analyses. Case studies will be presented, with emphasis on the "problematic" ones. For each case study the design will first be described, which will then be followed by description of the data monitoring model.


The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2012 program




2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.